Ret Proto-Oncogene antibody (Gln28, N-Term)

Catalog No. ABIN2350338

This anti-Ret Proto-Oncogene antibody is a Rabbit Polyclonal antibody detecting Ret Proto-Oncogene in WB, ELISA and FACS. Suitable for Human.

Quick Overview for Ret Proto-Oncogene antibody (Gln28, N-Term) (ABIN2350338)

Target: Ret Proto-Oncogene (RET)

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Ret Proto-Oncogene antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Flow Cytometry (FACS)

Product Details anti-Ret Proto-Oncogene Antibody

Binding Specificity: AA 13-44, Gln28, N-Term

Cross-Reactivity: Human

Cross-Reactivity (Details): Calculated cross reactivity: Hu

Characteristics: RET, NT (Q28) (RET, CDHF12, CDHR16, PTC, RET51, Proto-oncogene tyrosine-protein kinase receptor Ret, Cadherin family member 12, Proto-oncogene c-Ret, Soluble RET kinase fragment, Extracellular cell-membrane anchored RET cadherin 120kD fragment)

Purification: Purified by ammonium sulfate precipitation.

Immunogen: KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 13-44 in the N-terminal region of human RET, UniProt Accession #P07949.

Isotype: IgG

Application Details

Application Notes: Optimal working conditions should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: -20°C

Target Details for Ret Proto-Oncogene

Target: Ret Proto-Oncogene (RET)

Alternative Name: RET

UniProt: P07949

Pathways: RTK Signaling, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation